Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)

Clinical trial NCT05027815 · TERMINATED

Trial details

NCT number: NCT05027815
Sponsor: Jeffrey Bluestone
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV

Start date: 2021-09-23
Primary completion: 2022-03-02
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.